Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma
NY-ESO-1 is a member of the cancer-testis family of tumor antigens that elicits strong humoral and cellular immune responses in patients with NY-ESO-1–expressing cancers. Since CD4+ T lymphocytes play a critical role in generating antigen-specific cytotoxic T lymphocyte and antibody responses, we se...
Main Authors: | Jäger, Elke, Jäger, Dirk, Karbach, Julia, Chen, Yao-Tseng, Ritter, Gerd, Nagata, Yasuhiro, Gnjatic, Sacha, Stockert, Elisabeth, Arand, Michael, Old, Lloyd J., Knuth, Alexander |
---|---|
Format: | Online |
Language: | English |
Published: |
The Rockefeller University Press
2000
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195843/ |
Similar Items
-
Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
by: Jäger, Elke, et al.
Published: (1998) -
Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy
by: Matsuzaki, Junko, et al.
Published: (2015) -
NY-ESO-1 antibody as a novel tumour marker of gastric cancer
by: Fujiwara, S, et al.
Published: (2013) -
NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target
by: Lai, Jin-Ping, et al.
Published: (2012) -
NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma
by: Giesen, Eva, et al.
Published: (2014)